...
首页> 外文期刊>Pediatric Health, Medicine and Therapeutics >Evolution of membrane oxygenator technology for utilization during pediatric cardiopulmonary bypass
【24h】

Evolution of membrane oxygenator technology for utilization during pediatric cardiopulmonary bypass

机译:膜式充氧器技术在儿科体外循环中的应用

获取原文
           

摘要

The development of the membrane oxygenator for pediatric cardiopulmonary bypass has been an incorporation of ideology and technological advancements with contributions by many investigators throughout the past two centuries. With the pursuit of this technological achievement, the ability to care for mankind in the areas of cardiac surgery has been made possible. Heart disease can affect anyone within the general population, but one such segment that it can affect from inception includes children. Currently, congenital heart defects are the most common birth defects nationally and worldwide. A large meta-analysis study from 1930 to 2010 was conducted in review of published medical literature totaling 114 papers with a study population of 24,091,867 live births, and divulged a staggering incidence of congenital heart disease involving 164,396 subjects with diverse cardiac illnesses. The prevalence of these diseases increased from 0.6 per 1,000 live births from 1930–1934 to 9.1 per 1,000 live births after 1995. These data reveal an emphasis on a growing public health issue regarding congenital heart disease. This discovery displays a need for heightened awareness in the scientific and medical industrial community to accelerate investigative research on emerging cardiovascular devices in an effort to confront congenital anomalies. One such device that has evolved over the past several decades is the pediatric membrane oxygenator. The pediatric membrane oxygenator, in conjunction with the heart lung machine, assists in the repair of most congenital cardiac defects. Numerous children born with congenital heart disease with or without congestive heart failure have experienced improved clinical outcomes in quality of life, survival, and mortality as a result of the inclusion of this technology during their cardiac surgical procedure. The purpose of this review is to report a summary of the published medical and scientific literature related to development of the pediatric membrane oxygenator from its conceptual evolutionary stages to artificially supporting whole body perfusion in the modern pediatric cardiac surgical setting.
机译:在过去的两个世纪中,许多研究者的贡献已将用于小儿体外循环的膜式充氧器的发展纳入了意识形态和技术进步。随着这项技术成就的追求,使心脏外科手术领域的人类护理能力成为可能。心脏病可以影响到普通人群中的任何人,但是从一开始就可能影响到的这一部分人群包括儿童。当前,先天性心脏缺陷是全国和全世界最常见的出生缺陷。从1930年至2010年,进行了一项大型荟萃分析研究,回顾了已发表的医学文献,共有114篇论文,研究人群为24,091,867例活产,并揭示了涉及164,396例患有各种心脏病的先天性心脏病的惊人发病率。这些疾病的患病率从1930年至1934年的每千名活产婴儿0.6例上升到1995年以后的每千名活产婴儿9.1例。这些数据表明,人们对与先天性心脏病有关的公共卫生问题的关注日益增加。这一发现表明,科学和医学工业界需要提高认识,以加速对新兴心血管设备的调查研究,以应对先天性异常。在过去的几十年中发展起来的一种这样的装置是小儿膜充氧器。儿科膜充氧器与心肺机配合使用,有助于修复大多数先天性心脏缺陷。由于患有先天性心脏病而患有充血性心力衰竭或不患有充血性心力衰竭的许多儿童,由于在心脏外科手术过程中使用了该技术,因此在生活质量,生存率和死亡率方面都取得了改善的临床结果。这篇综述的目的是报告与儿科膜充氧器的发展有关的医学和科学文献的摘要,从其概念上的进化阶段到在现代儿科心脏外科手术环境中人工支持全身灌注。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号